The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
By cutting pain crises & boosting haemoglobin
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
IgAN is a rare, progressive kidney disease driven by abnormal IgA immune complexes that deposit in the kidneys
Medical experts point to a growing body of research linking energy drinks to liver injury
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
Advisory from Apollo Spectra Hospitals highlights hydration, nutrition, and screening as key preventive measures
Subscribe To Our Newsletter & Stay Updated
